Cyrus F Buhari, DO
Cardiovascular Disease (Cardiology) · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 23 years
- Graduated 2003
Offices
1 location · San Joaquin Cardiology Medical Group Inc · 7 clinicians in this group
Looking this up.
Hospitals listed: Dameron Hospital · Memorial Medical Center · St Joseph'S Medical Center of Stockton · Sutter Tracy Community Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Buhari’s office at (209) 464-7681 to ask if they take your plan before you enroll.
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Dameron HospitalStockton, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency departmentPart of Adventist Health, which runs 28 hospitals in 3 statesPatients rate it 2 of 5 · 58% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — MRSA Bacteremia: 18.373, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Memorial Medical CenterModesto, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.093, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.085, Oct 2024 – Sep 2025
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
- Sutter Tracy Community HospitalTracy, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Dameron Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| MRSA BacteremiaInfections | 18.373 | Worse | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.89 (0.46 to 1.32) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.1 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.5 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12 · 63 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 75 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.5 · 121 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.8 · 41 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.6 · 730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,121 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.3 (0.09 to 0.52) · 1,225 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.06 (0.59 to 5.54) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0 to 3.34) · 116 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.41 (0.76 to 4.05) · 363 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.35 (0.5 to 18.2) · 123 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.94 (0.72 to 9.16) · 109 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.25) · 74 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.36 (0 to 1.37) · 1,066 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.678 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 118 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.8 · 144 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 41.3 · 92 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 5.5 · 89 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 22.9 · 118 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 178 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.2 · 44 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 78 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.6 to 17.2) · 386 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.5) · 261 cases | No different | Jan 2024 – Dec 2024 |
What patients said (385 patients answered, 15% of those asked)
| Cleanliness | 3 |
| Nurse communication | 2 |
| Doctor communication | 1 |
| Communication about medicines | 1 |
| Discharge information | 1 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 2 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 70% |
| Doctors "always" communicated well | 66% |
| Staff "always" explained | 49% |
| Yes, staff "did" give patients this information | 77% |
| Yes, staff "did" give patients information about help after discharge | 72% |
| Doctors "always" explained things so they could understand | 62% |
| Doctors "always" listened carefully | 63% |
| Doctors "always" treated them with courtesy and respect | 74% |
| Patients who gave a rating of "9" or "10" (high) | 55% |
| Staff "always" explained new medications | 61% |
| Nurses "always" explained things so they could understand | 65% |
| Nurses "always" listened carefully | 65% |
| Nurses "always" treated them with courtesy and respect | 78% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 58% |
| Staff "always" explained possible side effects | 37% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
See every measure and the patient survey for Memorial Medical Center
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.093 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.085 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.3 (0.41 to 2.2) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.75 to 1.3) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 185.77 (144.66 to 226.88) · 146 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.2 · 105 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.2 · 237 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 513 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.4 · 640 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 278 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 4,882 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.03 to 0.42) · 10,183 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.38) · 10,422 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.4 (1.58 to 5.23) · 2,596 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.92 (0.45 to 3.38) · 845 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.1 (1.78 to 4.42) · 2,439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.71 (5.69 to 17.72) · 885 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.28 (3.75 to 10.81) · 829 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 563 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.72) · 9,080 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.4 · 283 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.389 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.485 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.507 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15 · 255 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 849 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 19.2 · 201 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.4 · 584 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 26.6 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 895 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.8 (3.3 to 6.9) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11 (8.4 to 14.3) · 285 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 273 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.7 · 108 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.4 · 341 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.2 to 16.1) · 2,334 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 717 cases | No different | Jan 2024 – Dec 2024 |
What patients said (655 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 44% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Tracy Community Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 2 better, 5 the same, 0 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.28 (0.21 to 2.34) · 363 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.41 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 9.3 · 35 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 130 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 156 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.6 · 51 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 835 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.42) · 1,800 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.46) · 1,820 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.09 (0.6 to 5.57) · 291 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.51 (0 to 3.16) · 138 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.19 (0.51 to 3.87) · 274 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (0 to 17.04) · 145 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.93 (0.72 to 9.15) · 133 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.34 (0 to 1.34) · 1,481 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 26 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.981 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.796 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 18.8 · 194 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -47.9 · 145 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5.1 · 154 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 42 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.3 to 16.7) · 504 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.7 to 1.5) · 104 cases | No different | Jan 2024 – Dec 2024 |
What patients said (443 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 85% |
| Doctors "always" explained things so they could understand | 77% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
Original Medicare doctor bills
$802,558
Medicare paid this office $802,558 for 1,195 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 91 | $111,313 | $1,210 |
| Return visit (30+ min) | 702 | $103,095 | $87 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 91 | $74,393 | $407 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $36,522 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $31,146 | $92 |
See all 46 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 91 | $111,313 | $1,210 |
| Return visit (30+ min) | 702 | $103,095 | $87 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 91 | $74,393 | $407 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 241 | $36,522 | $148 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 145 | $31,146 | $92 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 27 | $26,486 | $946 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 153 | $20,453 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 143 | $20,048 | $133 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 24 | $16,416 | $684 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 52 | $13,143 | $37 |
| Ultrasound of both sides of head and neck blood flow | 87 | $12,704 | $146 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 54 | $12,416 | $37 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 218 | $11,850 | $53 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 14 | $11,672 | $778 |
| Replacement of aortic valve through the skin and femoral artery | 18 | $9,795 | $544 |
| Ultrasound of leg arteries or artery grafts | 36 | $8,765 | $191 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 136 | $8,546 | $58 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 22 | $7,812 | $355 |
| Transitional care management services for problem of high complexity | 29 | $7,021 | $226 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $5,684 | $355 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 474 | $5,423 | $10 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $4,826 | $156 |
| New patient visit (60+ min) | 28 | $4,683 | $167 |
| Review by radiologist of both arms or legs arteries image | 29 | $3,794 | $131 |
| Complete ultrasound study of arm and leg arteries | 35 | $3,437 | $98 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 22 | $3,353 | $76 |
| Review by radiologist of abdominal aorta image | 29 | $2,936 | $101 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 18 | $2,779 | $154 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 12 | $2,479 | $138 |
| Injection, regadenoson, 0.1 mg | 114 | $2,436 | None |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 43 | $2,285 | $53 |
| Review by radiologist of additional artery image | 28 | $2,196 | $78 |
| Heart muscle strain imaging | 62 | $1,885 | $30 |
| Short return visit (20+ min) | 27 | $1,856 | $69 |
| Long return visit (40+ min) | 13 | $1,594 | $114 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 30 | $1,379 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 89 | $863 | $9 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 31 | $571 | $15 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 32 | $497 | $0 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 19 | $465 | $19 |
| Ultrasound of heart, follow-up | 23 | $445 | $19 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 31 | $402 | $13 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $341 | $24 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 17 | $218 | $13 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $115 | $10 |
| Injection, midazolam hydrochloride, per 1 mg | 32 | $5 | None |
Procedures Medicare counted
| Coronary angioplasty and stenting | 13 | More than 34% of doctors who do this |
| Leg revascularization (restoring blood flow) | 1-10 | None |
| Pacemaker insertion or repair | 12 | More than 63% of doctors who do this |
| Varicose vein removal | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 110 | 123 | 50 | 33 | – | 18 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 59 | 56 | 21 | 28 | 28 | 28 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 37 | 45 | 20 | 19 | – | 15 |
| Removal of plaque and insertion of stents in arteries of leg | 30 | 24 | 16 | 16 | – | – |
| Insertion of permanent leadless pacemaker using imaging guidance | 19 | – | 20 | 17 | – | – |
| Replacement of aortic valve through the skin and femoral artery | – | 14 | – | – | 14 | 18 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,195 Original Medicare patients in 2024. Average age 75 · Under 65 10% · 85 and older 15% · Women 47% · Also on Medicaid 42% · Health risk score 1.96. Above the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Coronary heart disease 56% · Diabetes 51% · Chronic kidney disease 44% · Heart failure 42% · Atrial fibrillation 38% · COPD 25% · Depression 18% · Stroke 16% · Cancer 13% · Dementia 12%.
The office billed $2,859,189, Medicare allowed $1,047,897 and paid $802,558; for 11,898 services of 104 kinds; $13,808 of it was for drugs given in the office and $788,750 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,195 | 11,898 | 75 | 1.96 | $2,859,189 | $802,558 |
| 2023 | 1,279 | 23,466 | 74 | 1.86 | $3,362,912 | $1,078,045 |
| 2022 | 1,332 | 15,558 | 74 | 1.80 | $3,851,045 | $1,237,868 |
| 2021 | 1,588 | 12,598 | 74 | 1.73 | $4,319,315 | $1,412,653 |
| 2020 | 1,340 | 18,016 | 74 | 1.96 | $5,524,946 | $1,804,539 |
| 2019 | 1,301 | 18,899 | 74 | 1.95 | $5,588,891 | $1,842,135 |
| 2018 | 1,411 | 19,814 | 74 | 1.96 | $4,385,829 | $1,382,949 |
| 2017 | 1,406 | 6,948 | 73 | 2.00 | $2,521,252 | $738,481 |
| 2016 | 1,405 | 4,748 | 73 | 2.04 | $1,326,857 | $401,897 |
| 2015 | 1,446 | 5,319 | 74 | 1.93 | $1,209,356 | $461,229 |
| 2014 | 1,196 | 3,018 | 74 | 1.83 | $671,987 | $248,943 |
| 2013 | 271 | 470 | 72 | 2.31 | $197,379 | $52,537 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 54 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 126 | $157,477 | $1,250 |
| Return visit (30+ min) | 769 | $135,309 | $92 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 126 | $105,186 | $417 |
| Injection, inclisiran, 1 mg | 25 | $98,766 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 303 | $50,014 | $158 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 192 | $32,099 | $64 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 26 | $29,219 | $1,044 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 37 | $26,906 | $727 |
| Injection, regadenoson, 0.1 mg | 149 | $26,004 | None |
| Ultrasound of both sides of head and neck blood flow | 110 | $17,305 | $153 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $16,689 | $97 |
| Ultrasound of leg arteries or artery grafts | 72 | $16,416 | $195 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 103 | $14,461 | $139 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 52 | $11,944 | $41 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 185 | $11,406 | $57 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 185 | $10,551 | $56 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $9,888 | $380 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $8,147 | $582 |
| Transitional care management services for problem of high complexity | 26 | $7,054 | $228 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 45 | $7,025 | $38 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 519 | $6,951 | $10 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 35 | $6,192 | $177 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $6,115 | $408 |
| New patient visit (60+ min) | 38 | $5,874 | $155 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 32 | $4,978 | $156 |
| Short return visit (20+ min) | 67 | $4,831 | $70 |
| Complete ultrasound study of arm and leg arteries | 42 | $4,586 | $109 |
| Review by radiologist of both arms or legs arteries image | 28 | $4,094 | $136 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 24 | $3,811 | $76 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 66 | $3,463 | $52 |
| Review by radiologist of abdominal aorta image | 28 | $3,283 | $106 |
| Review by radiologist of additional artery image | 28 | $2,642 | $83 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 31 | $1,550 | $43 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 18 | $1,461 | $41 |
| Long return visit (40+ min) | 13 | $1,351 | $104 |
| Programming of dual lead pacemaker system | 12 | $1,010 | $67 |
| Programming of single lead pacemaker system | 17 | $930 | $55 |
| Programming of dual lead implantable defibrillator system | 11 | $925 | $84 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 83 | $833 | $10 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 36 | $820 | $17 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 32 | $745 | $0 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 32 | $621 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $600 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $560 | $24 |
| Test to examine how well the lungs exchange gases | 11 | $539 | $49 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $523 | $19 |
| Injection of drug or substance under skin or into muscle | 25 | $429 | $12 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 27 | $427 | $16 |
| Test to determine lung volumes using gas dilution or washout | 11 | $412 | $37 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 11 | $394 | $33 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 11 | $364 | $33 |
| Ultrasound of heart, follow-up | 14 | $305 | $20 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 11 | $198 | $9 |
| Injection, midazolam hydrochloride, per 1 mg | 33 | $7 | None |
2022: 56 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 164 | $203,618 | $1,242 |
| Removal of plaque and insertion of stents in arteries of leg | 13 | $166,176 | $10,386 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 165 | $137,139 | $417 |
| Return visit (30+ min) | 747 | $136,608 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 316 | $52,791 | $159 |
| Injection, regadenoson, 0.1 mg | 185 | $35,905 | None |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 46 | $35,247 | $766 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 202 | $28,041 | $57 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 28 | $27,609 | $986 |
| Ultrasound of both sides of head and neck blood flow | 120 | $19,650 | $160 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 113 | $19,488 | $160 |
| Ultrasound of leg arteries or artery grafts | 75 | $17,135 | $204 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 17 | $16,542 | $871 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 237 | $14,086 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 222 | $13,986 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $13,672 | $83 |
| Transitional care management services for problem of high complexity | 46 | $11,918 | $234 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $8,414 | $205 |
| Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | 41 | $7,994 | $47 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $7,868 | $375 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 494 | $6,795 | $10 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 43 | $6,792 | $158 |
| Insertion of permanent leadless pacemaker using imaging guidance | 17 | $6,517 | $383 |
| Short return visit (20+ min) | 86 | $6,261 | $70 |
| Complete ultrasound study of arm and leg arteries | 56 | $5,941 | $106 |
| New patient visit (60+ min) | 36 | $5,821 | $162 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 11 | $5,288 | $378 |
| Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | 37 | $5,074 | $42 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 13 | $4,770 | $145 |
| Review by radiologist of additional artery image | 30 | $4,103 | $84 |
| Review by radiologist of both arms or legs arteries image | 29 | $4,040 | $139 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 22 | $3,675 | $84 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 62 | $3,568 | $58 |
| Review by radiologist of abdominal aorta image | 32 | $3,481 | $109 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,659 | $242 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 48 | $2,327 | $23 |
| Programming of single lead pacemaker system | 34 | $2,138 | $52 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 38 | $1,930 | $44 |
| Long return visit (40+ min) | 12 | $1,654 | $138 |
| Programming of dual lead pacemaker system | 20 | $1,548 | $60 |
| Programming of dual lead implantable defibrillator system | 19 | $1,443 | $60 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,291 | $108 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 24 | $1,168 | $21 |
| Ultrasound of heart with probe in esophagus, with report | 13 | $1,161 | $89 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 47 | $1,013 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 44 | $972 | $18 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 90 | $953 | $10 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 23 | $951 | $20 |
| Follow-up observation care per day, typically 25 minutes | 12 | $924 | $54 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 21 | $739 | $25 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; third dose | 17 | $714 | $42 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 38 | $633 | $0 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 40 | $630 | $15 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 24 | $620 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 17 | $378 | $9 |
| Injection, midazolam hydrochloride, per 1 mg | 39 | $7 | None |
2021: 61 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 177 | $232,716 | $1,286 |
| Removal of plaque and insertion of stents in arteries of leg | 13 | $192,753 | $12,047 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 178 | $153,087 | $422 |
| Return visit (30+ min) | 742 | $140,798 | $100 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 374 | $64,189 | $167 |
| Injection, regadenoson, 0.1 mg | 190 | $36,732 | None |
| Short return visit (20+ min) | 374 | $31,337 | $62 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 199 | $28,690 | $59 |
| Ultrasound of leg arteries or artery grafts | 114 | $27,605 | $219 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 39 | $24,542 | $614 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 141 | $22,729 | $159 |
| Ultrasound of both sides of head and neck blood flow | 125 | $21,209 | $168 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 15 | $19,725 | $986 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 19 | $18,906 | $900 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $16,589 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 222 | $14,852 | $59 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 233 | $14,377 | $57 |
| Transitional care management services for problem of high complexity | 33 | $10,136 | $236 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 606 | $8,789 | $11 |
| Complete ultrasound study of arm and leg arteries | 77 | $8,556 | $111 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $8,049 | $383 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 14 | $7,808 | $156 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 49 | $7,613 | $152 |
| Insertion of permanent leadless pacemaker using imaging guidance | 20 | $6,863 | $343 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; third dose | 145 | $6,145 | $42 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 33 | $6,063 | $184 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose | 138 | $5,850 | $42 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose | 135 | $5,486 | $41 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 83 | $5,141 | $61 |
| New patient visit (60+ min) | 30 | $5,075 | $169 |
| Programming of dual lead implantable defibrillator system | 39 | $5,003 | $76 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $4,803 | $343 |
| Review by radiologist of additional artery image | 20 | $3,919 | $89 |
| Programming of dual lead pacemaker system | 36 | $3,733 | $60 |
| Programming of single lead pacemaker system | 46 | $3,535 | $54 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $3,517 | $251 |
| Review by radiologist of both arms or legs arteries image | 21 | $3,190 | $145 |
| Long return visit (40+ min) | 22 | $2,807 | $128 |
| Review by radiologist of abdominal aorta image | 21 | $2,509 | $114 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 13 | $2,145 | $86 |
| Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted; third dose | 46 | $1,950 | $42 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 22 | $1,437 | $45 |
| New patient visit (45+ min) | 11 | $1,350 | $123 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 102 | $1,143 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 49 | $1,031 | $20 |
| Ultrasound of heart with probe in esophagus, with report | 11 | $996 | $91 |
| Test to examine how well the lungs exchange gases | 16 | $877 | $52 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 19 | $686 | $31 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 16 | $682 | $40 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 16 | $667 | $24 |
| Test to determine lung volumes using gas dilution or washout | 16 | $645 | $38 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $642 | $46 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 25 | $620 | $22 |
| Programming of cardiac rhythm monitor system | 11 | $514 | $47 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 19 | $478 | $9 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 22 | $410 | $0 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 19 | $378 | $20 |
| Administration of influenza virus vaccine | 19 | $342 | $18 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 13 | $287 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $234 | $16 |
| Injection, midazolam hydrochloride, per 1 mg | 23 | $5 | None |
2020: 60 services
| Removal of plaque and insertion of stents in arteries of leg | 16 | $306,258 | $12,761 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 206 | $272,469 | $1,304 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 206 | $174,804 | $419 |
| Removal of plaque in arteries of leg | 16 | $114,243 | $5,193 |
| Return visit (30+ min) | 704 | $106,210 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 429 | $73,251 | $164 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 45 | $53,162 | $949 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 32 | $46,283 | $1,029 |
| Injection, regadenoson, 0.1 mg | 234 | $44,588 | None |
| Short return visit (20+ min) | 517 | $42,927 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 215 | $36,858 | $60 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 191 | $34,642 | $167 |
| Ultrasound of leg arteries or artery grafts | 85 | $24,236 | $214 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 34 | $20,902 | $597 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 77 | $20,006 | $85 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 32 | $19,833 | $161 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 255 | $16,300 | $59 |
| Transitional care management services for problem of high complexity | 47 | $13,449 | $207 |
| Ultrasound of both sides of head and neck blood flow | 78 | $12,815 | $162 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 189 | $12,409 | $60 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $9,604 | $384 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 51 | $8,988 | $158 |
| Replacement of aortic valve through the skin and femoral artery | 14 | $8,710 | $622 |
| Review by radiologist of additional artery image | 43 | $8,067 | $92 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 504 | $7,394 | $12 |
| Review by radiologist of both arms or legs arteries image | 44 | $6,800 | $148 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 12 | $6,614 | $367 |
| New patient visit (60+ min) | 37 | $6,127 | $166 |
| Programming of dual lead implantable defibrillator system | 43 | $6,068 | $67 |
| Telephone medical discussion with physician, 11-20 minutes | 88 | $5,923 | $58 |
| Complete ultrasound study of arm and leg arteries | 51 | $5,725 | $110 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 30 | $5,580 | $186 |
| Review by radiologist of abdominal aorta image | 43 | $5,155 | $117 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 80 | $5,032 | $63 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 25 | $4,371 | $84 |
| Programming of single lead pacemaker system | 48 | $2,990 | $43 |
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 37 | $2,853 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $2,806 | $44 |
| Programming of dual lead pacemaker system | 40 | $2,768 | $46 |
| Telephone medical discussion with physician, 21-30 minutes | 21 | $2,019 | $84 |
| Emergency department visit with high level of medical decision making | 14 | $1,997 | $143 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 16 | $1,952 | $20 |
| Review by radiologist of arm or leg artery image | 13 | $1,938 | $138 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 45 | $1,532 | $21 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 28 | $1,505 | $31 |
| Long return visit (40+ min) | 16 | $1,484 | $93 |
| Long return visit (40+ min) | 13 | $1,406 | $108 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 55 | $1,264 | $22 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 39 | $1,068 | $9 |
| Follow-up observation care per day, typically 35 minutes | 11 | $1,040 | $87 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 21 | $901 | $21 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 79 | $811 | $10 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 46 | $795 | $0 |
| Programming of cardiac rhythm monitor system | 11 | $646 | $43 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 18 | $584 | $23 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $297 | $20 |
| Administration of influenza virus vaccine | 11 | $212 | $18 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 11 | $211 | $19 |
| Infusion, normal saline solution, 250 cc | 32 | $16 | None |
| Injection, midazolam hydrochloride, per 1 mg | 46 | $8 | None |
2019: 57 services
| Removal of plaque and insertion of stents in arteries of leg | 21 | $406,315 | $13,544 |
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 185 | $236,384 | $1,238 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 188 | $159,280 | $412 |
| Removal of plaque in arteries of leg | 19 | $157,388 | $7,495 |
| Return visit (30+ min) | 773 | $121,739 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 444 | $79,778 | $168 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 49 | $54,329 | $921 |
| Short return visit (20+ min) | 523 | $41,422 | $56 |
| Ultrasound evaluation of blood vessel with review by radiologist, initial vessel | 29 | $40,191 | $1,086 |
| Injection, regadenoson, 0.1 mg | 200 | $37,933 | None |
| Balloon dilation of artery of leg, initial vessel | 11 | $30,905 | $2,377 |
| Ultrasound of leg arteries or artery grafts | 109 | $28,063 | $218 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 152 | $26,999 | $163 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 163 | $23,703 | $59 |
| Destruction of first incompetent vein of arm or leg using radiofrequency and imaging guidance | 11 | $18,125 | $1,208 |
| Ultrasound evaluation of blood vessel with review by radiologist, each additional vessel | 28 | $18,103 | $165 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 244 | $16,531 | $59 |
| Ultrasound of both sides of head and neck blood flow | 95 | $16,036 | $167 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 24 | $14,626 | $609 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 68 | $14,113 | $85 |
| Transitional care management services for problem of high complexity | 50 | $12,470 | $192 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 59 | $12,071 | $201 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 61 | $11,421 | $163 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 632 | $11,292 | $13 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 153 | $9,878 | $60 |
| Review by radiologist of additional artery image | 52 | $7,997 | $70 |
| New patient visit (60+ min) | 48 | $7,670 | $160 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,344 | $432 |
| Review by radiologist of both arms or legs arteries image | 47 | $7,256 | $148 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 14 | $5,765 | $412 |
| Review by radiologist of abdominal aorta image | 49 | $5,618 | $110 |
| Insertion of permanent leadless pacemaker using imaging guidance | 19 | $5,415 | $285 |
| Complete ultrasound study of arm and leg arteries | 46 | $4,982 | $108 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 57 | $3,974 | $69 |
| Programming of dual lead implantable defibrillator system | 34 | $3,460 | $69 |
| Insertion of needle or tube into artery of arm or leg | 18 | $3,433 | $191 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 57 | $3,253 | $43 |
| Review by radiologist of arm or leg artery image | 17 | $3,050 | $139 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $2,837 | $218 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 14 | $2,459 | $88 |
| Programming of dual lead pacemaker system | 34 | $2,060 | $51 |
| Long return visit (40+ min) | 14 | $1,680 | $120 |
| Programming of single lead pacemaker system | 32 | $1,481 | $46 |
| Long return visit (40+ min) | 16 | $1,445 | $90 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 53 | $1,319 | $9 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 113 | $1,224 | $10 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $1,106 | $50 |
| Follow-up observation care per day, typically 35 minutes | 12 | $1,023 | $85 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 14 | $1,020 | $22 |
| Test to examine how well the lungs exchange gases | 22 | $990 | $45 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 56 | $929 | $0 |
| Test to determine lung volumes using gas dilution or washout | 22 | $812 | $37 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 32 | $706 | $21 |
| Remote evaluations of implantable heart and blood vessel monitor or loop recorder system with technician analysis, review, and report, up to 30 days | 14 | $495 | $11 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 11 | $192 | $17 |
| Infusion, normal saline solution, 250 cc | 188 | $95 | None |
| Injection, midazolam hydrochloride, per 1 mg | 53 | $9 | None |
2018: 47 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 171 | $209,519 | $1,225 |
| Removal of plaque in arteries of leg | 16 | $169,221 | $8,906 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 170 | $118,001 | $347 |
| Return visit (30+ min) | 747 | $105,316 | $75 |
| Insertion of tube into abdominal, pelvic, or leg artery, initial third order branch | 50 | $59,431 | $1,043 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 328 | $56,596 | $165 |
| Short return visit (20+ min) | 562 | $42,737 | $53 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 195 | $36,514 | $162 |
| Injection, regadenoson, 0.1 mg | 187 | $32,875 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 195 | $26,392 | $59 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 91 | $18,473 | $84 |
| Ultrasound of leg arteries or artery grafts | 75 | $16,168 | $216 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 260 | $15,728 | $57 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 208 | $13,656 | $58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $12,264 | $409 |
| Ultrasound of both sides of head and neck blood flow | 74 | $12,226 | $165 |
| Insertion of tube into abdominal, pelvic, or leg artery, each first order branch | 11 | $11,628 | $1,057 |
| Replacement of aortic valve by through femoral artery | 15 | $10,914 | $728 |
| Ultrasound study of arm or leg veins with compression and maneuvers | 58 | $9,967 | $161 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 54 | $9,871 | $179 |
| Review by radiologist of both arms or legs arteries image | 60 | $9,857 | $162 |
| New patient visit (60+ min) | 65 | $8,944 | $138 |
| Review by radiologist of additional artery image | 63 | $8,849 | $73 |
| Review by radiologist of abdominal aorta image | 62 | $7,356 | $113 |
| Transitional care management services for problem of high complexity | 34 | $6,932 | $187 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 16 | $6,250 | $391 |
| Implantation or replacement of permanent ventricular pacemaker | 20 | $6,234 | $312 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 367 | $5,475 | $12 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 20 | $4,302 | $215 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 72 | $3,866 | $43 |
| Review by radiologist of arm or leg artery image | 19 | $3,119 | $142 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 15 | $2,694 | $90 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 35 | $1,777 | $51 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 59 | $1,637 | $9 |
| Test to examine how well the lungs exchange gases | 36 | $1,587 | $44 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 137 | $1,443 | $10 |
| Complete ultrasound study of arm and leg arteries | 13 | $1,428 | $110 |
| Test to determine lung volumes using gas dilution or washout | 37 | $1,377 | $37 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,345 | $71 |
| Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 70 | $1,167 | $0 |
| Long return visit (40+ min) | 14 | $1,158 | $83 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 12 | $654 | $54 |
| Injection, aminophyllin, up to 250 mg | 69 | $393 | None |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 11 | $181 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11 | $121 | $11 |
| Infusion, normal saline solution, 250 cc | 187 | $86 | None |
| Injection, midazolam hydrochloride, per 1 mg | 58 | $10 | None |
2017: 32 services
| Nuclear medicine studies of blood flow in heart muscle at rest and with stress | 140 | $167,920 | $1,191 |
| Return visit (30+ min) | 782 | $118,128 | $77 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 141 | $65,486 | $231 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 332 | $61,243 | $182 |
| Short return visit (20+ min) | 625 | $54,718 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 168 | $29,697 | $161 |
| Injection, regadenoson, 0.1 mg | 157 | $27,605 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 389 | $20,751 | $50 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 145 | $18,645 | $58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 31 | $17,440 | $415 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 67 | $15,568 | $85 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 194 | $14,421 | $61 |
| Ultrasound of both sides of head and neck blood flow | 89 | $14,266 | $159 |
| New patient visit (60+ min) | 74 | $11,260 | $152 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 53 | $10,127 | $188 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 17 | $7,457 | $414 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 436 | $7,141 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 18 | $4,199 | $233 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 17 | $3,435 | $95 |
| Implantation or replacement of permanent ventricular pacemaker | 11 | $3,243 | $295 |
| Ultrasound of leg arteries or artery grafts | 15 | $3,160 | $211 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 24 | $1,618 | $65 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 27 | $1,331 | $49 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,255 | $90 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 18 | $1,252 | $70 |
| Test to examine how well the lungs exchange gases | 28 | $1,206 | $43 |
| Test to determine lung volumes using gas dilution or washout | 28 | $989 | $35 |
| Injection, aminophyllin, up to 250 mg | 152 | $968 | None |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 59 | $609 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 22 | $365 | $16 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 22 | $255 | $11 |
| Infusion, normal saline solution, 250 cc | 156 | $63 | None |
2016: 24 services
| Return visit (30+ min) | 660 | $94,006 | $79 |
| Short return visit (20+ min) | 635 | $55,476 | $53 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 279 | $52,530 | $182 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 58 | $23,743 | $409 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 428 | $22,687 | $51 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 67 | $13,985 | $203 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $13,859 | $420 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 77 | $12,980 | $162 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 58 | $10,973 | $95 |
| Injection, regadenoson, 0.1 mg | 58 | $9,816 | None |
| Ultrasound of both sides of head and neck blood flow | 61 | $9,201 | $151 |
| Insertion of implantable defibrillator system | 12 | $8,583 | $715 |
| New patient visit (60+ min) | 48 | $7,077 | $147 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 114 | $6,301 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 58 | $5,846 | $58 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 368 | $5,646 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 35 | $4,382 | $84 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 13 | $3,116 | $240 |
| New patient visit (45+ min) | 13 | $1,750 | $135 |
| Long return visit (40+ min) | 15 | $1,535 | $102 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 15 | $774 | $52 |
| Test to examine how well the lungs exchange gases | 16 | $740 | $46 |
| Test to determine lung volumes using gas dilution or washout | 16 | $568 | $36 |
| Infusion, normal saline solution, 250 cc | 58 | $21 | None |
2015: 24 services
| Return visit (30+ min) | 607 | $79,837 | $84 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 125 | $52,637 | $411 |
| Short return visit (20+ min) | 665 | $51,739 | $51 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 125 | $33,824 | $132 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 185 | $33,225 | $164 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 173 | $32,585 | $187 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 401 | $21,157 | $51 |
| Injection, regadenoson, 0.1 mg | 125 | $21,117 | None |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 151 | $20,387 | $59 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 70 | $15,606 | $220 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $11,823 | $438 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 166 | $11,086 | $54 |
| New patient visit (60+ min) | 67 | $10,713 | $160 |
| Ultrasound of both sides of head and neck blood flow | 50 | $7,695 | $154 |
| Insertion of implantable defibrillator system | 11 | $7,577 | $689 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $6,851 | $85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 374 | $5,438 | $13 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 20 | $4,676 | $234 |
| Ultrasound of heart with probe in esophagus, with report | 16 | $1,690 | $99 |
| Emergency department visit with high level of medical decision making | 12 | $1,672 | $139 |
| Long return visit (40+ min) | 16 | $1,459 | $91 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 13 | $883 | $68 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 11 | $127 | $11 |
| Infusion, normal saline solution, 250 cc | 124 | $39 | None |
2014: 22 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 253 | $44,896 | $163 |
| Short return visit (20+ min) | 547 | $44,348 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 231 | $31,763 | $58 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 345 | $18,586 | $52 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 60 | $12,973 | $213 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 31 | $12,697 | $410 |
| Return visit (30+ min) | 136 | $12,005 | $82 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 31 | $8,173 | $132 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 14 | $7,140 | $446 |
| New patient visit (60+ min) | 39 | $6,353 | $163 |
| Injection, regadenoson, 0.1 mg | 31 | $5,115 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 26 | $4,878 | $188 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 54 | $3,474 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $3,270 | $84 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,637 | $240 |
| Long return visit (40+ min) | 18 | $1,968 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 134 | $1,926 | $14 |
| Test to examine how well the lungs exchange gases | 21 | $845 | $40 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 22 | $840 | $38 |
| Test to determine lung volumes using gas dilution or washout | 21 | $703 | $33 |
| Smoking and tobacco use intensive counseling, more than 10 minutes | 18 | $400 | $20 |
| Infusion, normal saline solution, 250 cc | 31 | $8 | None |
2013: 12 services
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 41 | $9,017 | $220 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $6,517 | $159 |
| Long return visit (40+ min) | 27 | $4,303 | $110 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $2,923 | $56 |
| Return visit (30+ min) | 32 | $2,878 | $85 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,573 | $234 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 25 | $2,530 | $82 |
| New patient visit (60+ min) | 13 | $2,044 | $157 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 35 | $1,710 | $49 |
| Short return visit (20+ min) | 23 | $1,366 | $59 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 19 | $287 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 11 | $100 | $6 |
Medicaid work
$137,518 in 2024
Medicaid paid $137,518 for 2,449 billed services this clinician did in 2024, up to 108 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 376 | $50,296 |
| Return visit (30+ min) | 657 | $27,039 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 222 | $12,729 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 280 | $12,635 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 224 | $10,444 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 339 | $9,156 |
| 1ST HOSP IP/OBS HIGH 75 | 90 | $6,933 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 235 | $6,799 |
| CARDIOVASCULAR STRESS TEST | 13 | $1,103 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 13 | $385 |
| 2024 | 2,449 | 10 | 108 | $137,518 |
| 2023 | 3,309 | 16 | 121 | $194,248 |
| 2022 | 2,403 | 11 | 77 | $167,957 |
| 2021 | 3,221 | 12 | 87 | $202,713 |
| 2020 | 2,790 | 11 | 62 | $164,328 |
| 2019 | 3,019 | 16 | 98 | $214,447 |
| 2018 | 2,353 | 10 | 88 | $140,720 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 504 | $70,291 |
| Return visit (30+ min) | 939 | $35,106 |
| Injection, regadenoson, 0.1 mg | 68 | $14,479 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 499 | $13,730 |
| CARDIOVASCULAR STRESS TEST | 132 | $12,022 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 485 | $11,979 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 242 | $11,599 |
| 1ST HOSP IP/OBS HIGH 75 | 81 | $6,073 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 162 | $5,521 |
| Remote physiologic monitoring treatment management services, clinical staff/physician/other qualified health care professional time in a calendar month requiring interactive communication with the patient/caregiver during the month; first 20 minutes | 116 | $4,513 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | $2,695 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 17 | $1,850 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 499 | $63,954 |
| Return visit (30+ min) | 711 | $29,918 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 413 | $15,672 |
| Injection, regadenoson, 0.1 mg | 76 | $15,568 |
| CARDIOVASCULAR STRESS TEST | 140 | $14,979 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 384 | $10,423 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $5,824 |
| 1ST HOSP IP/OBS HIGH 75 | 64 | $5,312 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 12 | $3,240 |
| Remote monitoring of physiologic parameter(s) (eg, weight, blood pressure, pulse oximetry, respiratory flow rate), initial; device(s) supply with daily recording(s) or programmed alert(s) transmission, each 30 days | 78 | $2,737 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 14 | $329 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 671 | $87,666 |
| Return visit (30+ min) | 722 | $33,006 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 491 | $18,042 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 548 | $14,120 |
| CARDIOVASCULAR STRESS TEST | 163 | $13,232 |
| Injection, regadenoson, 0.1 mg | 73 | $13,024 |
| 1ST HOSP IP/OBS HIGH 75 | 82 | $6,514 |
| Short return visit (20+ min) | 267 | $6,454 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 33 | $3,114 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; second dose | 66 | $2,630 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, preservative free, 100 mcg/0.5 mL dosage; first dose | 63 | $2,470 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 42 | $2,439 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 514 | $64,782 |
| Return visit (30+ min) | 603 | $25,465 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 530 | $20,514 |
| 1ST HOSP IP/OBS HIGH 75 | 147 | $12,424 |
| CARDIOVASCULAR STRESS TEST | 144 | $9,803 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 399 | $9,013 |
| Short return visit (20+ min) | 350 | $8,756 |
| Injection, regadenoson, 0.1 mg | 52 | $7,748 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 12 | $3,751 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 13 | $1,383 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 26 | $690 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 543 | $82,951 |
| Return visit (30+ min) | 747 | $31,310 |
| CARDIOVASCULAR STRESS TEST | 177 | $14,733 |
| Injection, regadenoson, 0.1 mg | 79 | $14,358 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 555 | $13,599 |
| Myocardial perfusion imaging, tomographic (SPECT) (including attenuation correction, qualitative or quantitative wall motion, ejection fraction by first pass or gated technique, additional quantification, when performed); multiple studies, at rest and/or stress (exercise or pharmacologic) and/or redistribution and/or rest reinjection | 28 | $13,316 |
| 1ST HOSP IP/OBS HIGH 75 | 138 | $12,252 |
| Short return visit (20+ min) | 314 | $7,644 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 157 | $5,794 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 82 | $4,727 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 92 | $3,614 |
| Technetium tc-99m tetrofosmin, diagnostic, per study dose | 13 | $3,583 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 498 | $55,451 |
| Return visit (30+ min) | 634 | $29,971 |
| Injection, regadenoson, 0.1 mg | 84 | $12,619 |
| CARDIOVASCULAR STRESS TEST | 141 | $9,667 |
| Short return visit (20+ min) | 300 | $8,990 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 190 | $7,714 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 304 | $7,517 |
| 1ST HOSP IP/OBS HIGH 75 | 91 | $7,025 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 39 | $1,551 |
| Infusion, normal saline solution, 250 cc | 72 | $216 |
Drugs they prescribed that Part D paid
$2,723,839
Pharmacies billed $2,723,839 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
12,079 generic and 2,644 brand-name prescriptions · $2,723,839 in drug cost · 49 antibiotic prescriptions to 40 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 712 | $779,878 | $1,095 |
| Jardiance | 418 | $444,985 | $1,065 |
| Xarelto | 262 | $306,471 | $1,170 |
| Entresto | 236 | $301,834 | $1,279 |
| Ozempic | 181 | $178,898 | $988 |
See all 73 drugs
| Eliquis | 712 | $779,878 | $1,095 |
| Jardiance | 418 | $444,985 | $1,065 |
| Xarelto | 262 | $306,471 | $1,170 |
| Entresto | 236 | $301,834 | $1,279 |
| Ozempic | 181 | $178,898 | $988 |
| Repatha Sureclick | 213 | $161,254 | $757 |
| Brilinta | 95 | $73,154 | $770 |
| Vascepa | 79 | $54,642 | $692 |
| Farxiga | 48 | $52,025 | $1,084 |
| Icosapent Ethyl | 114 | $44,802 | $393 |
| Atorvastatin | 1,785 | $22,300 | $12 |
| Verquvo | 11 | $22,004 | $2,000 |
| Metoprolol | 1,301 | $21,095 | $16 |
| Ranolazine Er | 105 | $14,666 | $140 |
| Clopidogrel | 802 | $11,858 | $15 |
| Praluent | 23 | $11,857 | $516 |
| Losartan | 984 | $11,261 | $11 |
| Ezetimibe | 317 | $10,905 | $34 |
| Rosuvastatin | 367 | $7,938 | $22 |
| Amlodipine Besylate | 843 | $5,955 | $7 |
| Carvedilol | 602 | $5,886 | $10 |
| Fenofibrate | 160 | $5,292 | $33 |
| Metoprolol | 603 | $4,944 | $8 |
| Potassium Chloride | 200 | $4,515 | $23 |
| Lisinopril | 499 | $4,176 | $8 |
| Furosemide | 600 | $4,046 | $7 |
| Isosorbide Mononitrate Er | 245 | $3,937 | $16 |
| Hydralazine | 270 | $3,775 | $14 |
| Amiodarone | 108 | $3,457 | $32 |
| Spironolactone | 319 | $3,242 | $10 |
| Midodrine | 23 | $3,041 | $132 |
| Losartan-Hydrochlorothiazide | 142 | $2,893 | $20 |
| Nebivolol | 28 | $2,471 | $88 |
| Pradaxa | 12 | $2,460 | $205 |
| Dexlansoprazole Dr | 12 | $2,345 | $195 |
| Pantoprazole | 132 | $2,128 | $16 |
| Nitroglycerin | 79 | $2,022 | $26 |
| Nifedipine Er | 53 | $1,633 | $31 |
| Flecainide Acetate | 18 | $1,592 | $88 |
| Fenofibrate | 51 | $1,463 | $29 |
| Valsartan | 41 | $1,434 | $35 |
| Levothyroxine | 64 | $1,230 | $19 |
| Diltiazem 24hr Er (Cd) | 70 | $1,144 | $16 |
| Simvastatin | 101 | $1,135 | $11 |
| Diltiazem 24hr Er | 33 | $1,003 | $30 |
| Diltiazem 24hr Er (Xr) | 21 | $981 | $47 |
| Valsartan-Hydrochlorothiazide | 28 | $972 | $35 |
| Hydrochlorothiazide | 234 | $958 | $4 |
| Cilostazol | 21 | $948 | $45 |
| Benazepril | 77 | $882 | $11 |
| Metformin | 61 | $799 | $13 |
| Labetalol | 26 | $780 | $30 |
| Metolazone | 17 | $777 | $46 |
| Tamsulosin | 46 | $680 | $15 |
| Pravastatin | 31 | $568 | $18 |
| Diltiazem | 29 | $522 | $18 |
| Lisinopril-Hydrochlorothiazide | 36 | $401 | $11 |
| Amlodipine Besylate-Benazepril | 21 | $368 | $18 |
| Digoxin | 19 | $365 | $19 |
| Propranolol | 12 | $358 | $30 |
| Allopurinol | 36 | $358 | $10 |
| Famotidine | 25 | $333 | $13 |
| Warfarin | 19 | $289 | $15 |
| Omeprazole | 22 | $262 | $12 |
| Gabapentin | 16 | $255 | $16 |
| Glipizide | 19 | $211 | $11 |
| Clonidine | 34 | $199 | $6 |
| Verapamil Er | 11 | $166 | $15 |
| Atenolol | 25 | $149 | $6 |
| Klor-Con 10 | 13 | $97 | $7 |
| Escitalopram | 15 | $86 | $6 |
| Cephalexin | 14 | $76 | $5 |
| Azithromycin | 12 | $50 | $4 |
Year by year
| 2024 | 14,723 | 1,905 | None | 18% | $2,723,839 |
| 2023 | 13,286 | 1,864 | 0% (0) | None | $2,398,229 |
| 2022 | 12,411 | 1,660 | None | None | $1,736,357 |
| 2021 | 13,307 | 1,595 | None | 15% | $1,595,838 |
| 2020 | 11,089 | 1,410 | None | 17% | $1,212,583 |
| 2019 | 3,716 | 927 | None | 15% | $349,806 |
| 2018 | 1,973 | 534 | None | 15% | $183,610 |
| 2017 | 1,767 | 451 | None | 19% | $119,964 |
| 2016 | 1,755 | 386 | None | 22% | $105,380 |
| 2015 | 1,414 | 315 | None | 18% | $77,119 |
| 2014 | 1,163 | 291 | 2% (24) | 20% | $56,852 |
| 2013 | 547 | 153 | 2% (11) | 23% | $33,477 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 67 drugs
| Eliquis | 711 | $738,633 | $1,039 |
| Entresto | 217 | $309,289 | $1,425 |
| Jardiance | 205 | $287,256 | $1,401 |
| Xarelto | 220 | $275,885 | $1,254 |
| Repatha Sureclick | 162 | $125,769 | $776 |
| Brilinta | 108 | $95,866 | $888 |
| Vascepa | 123 | $83,680 | $680 |
| Ozempic | 35 | $36,908 | $1,055 |
| Atorvastatin | 1,658 | $34,911 | $21 |
| Metoprolol | 1,237 | $28,551 | $23 |
| Icosapent Ethyl | 75 | $26,562 | $354 |
| Farxiga | 19 | $24,101 | $1,268 |
| Ranolazine Er | 134 | $22,432 | $167 |
| Verquvo | 21 | $18,292 | $871 |
| Ezetimibe | 238 | $16,078 | $68 |
| Clopidogrel | 777 | $15,743 | $20 |
| Losartan | 733 | $13,974 | $19 |
| Praluent | 18 | $11,840 | $658 |
| Amlodipine Besylate | 894 | $10,443 | $12 |
| Rosuvastatin | 331 | $9,852 | $30 |
| Fenofibrate | 164 | $8,503 | $52 |
| Carvedilol | 516 | $8,361 | $16 |
| Amiodarone | 98 | $8,299 | $85 |
| Metoprolol | 576 | $7,429 | $13 |
| Lisinopril | 521 | $6,849 | $13 |
| Hydralazine | 273 | $5,798 | $21 |
| Potassium Chloride | 182 | $5,643 | $31 |
| Furosemide | 515 | $5,010 | $10 |
| Isosorbide Mononitrate Er | 216 | $4,926 | $23 |
| Midodrine | 26 | $4,418 | $170 |
| Nitroglycerin | 102 | $4,123 | $40 |
| Spironolactone | 244 | $3,527 | $14 |
| Fenofibrate | 60 | $3,437 | $57 |
| Valsartan | 44 | $2,684 | $61 |
| Pantoprazole | 134 | $2,684 | $20 |
| Losartan-Hydrochlorothiazide | 108 | $2,634 | $24 |
| Nebivolol | 31 | $2,429 | $78 |
| Diltiazem 24hr Er (Cd) | 60 | $1,850 | $31 |
| Simvastatin | 98 | $1,532 | $16 |
| Diltiazem 24hr Er (Xr) | 22 | $1,497 | $68 |
| Benazepril | 80 | $1,413 | $18 |
| Nifedipine Er | 48 | $1,322 | $28 |
| Hydrochlorothiazide | 234 | $1,284 | $5 |
| Diltiazem | 37 | $1,280 | $35 |
| Diltiazem 24hr Er | 31 | $1,163 | $38 |
| Propranolol | 19 | $1,133 | $60 |
| Valsartan-Hydrochlorothiazide | 34 | $991 | $29 |
| Pentoxifylline | 12 | $981 | $82 |
| Levothyroxine | 42 | $961 | $23 |
| Atenolol | 51 | $890 | $17 |
| Verapamil Er | 18 | $889 | $49 |
| Lisinopril-Hydrochlorothiazide | 27 | $751 | $28 |
| Warfarin | 43 | $721 | $17 |
| Omeprazole | 30 | $647 | $22 |
| Klor-Con 10 | 21 | $579 | $28 |
| Metformin | 26 | $485 | $19 |
| Pravastatin | 24 | $449 | $19 |
| Clonidine | 19 | $399 | $21 |
| Amlodipine Besylate-Benazepril | 17 | $395 | $23 |
| Dilt-Xr | 16 | $354 | $22 |
| Tamsulosin | 24 | $349 | $15 |
| Famotidine | 14 | $291 | $21 |
| Klor-Con 8 | 12 | $253 | $21 |
| Gabapentin | 12 | $217 | $18 |
| Allopurinol | 25 | $202 | $8 |
| Glimepiride | 11 | $135 | $12 |
| Cephalexin | 13 | $130 | $10 |
2022: 68 drugs
| Eliquis | 548 | $550,458 | $1,004 |
| Xarelto | 196 | $235,950 | $1,204 |
| Entresto | 147 | $189,985 | $1,292 |
| Brilinta | 139 | $120,089 | $864 |
| Jardiance | 81 | $111,017 | $1,371 |
| Repatha Sureclick | 131 | $99,386 | $759 |
| Vascepa | 132 | $77,931 | $590 |
| Ranolazine Er | 128 | $26,319 | $206 |
| Metoprolol | 1,248 | $23,988 | $19 |
| Atorvastatin | 1,473 | $22,613 | $15 |
| Icosapent Ethyl | 40 | $16,330 | $408 |
| Praluent | 29 | $15,610 | $538 |
| Clopidogrel | 788 | $12,153 | $15 |
| Nexlizet | 20 | $11,645 | $582 |
| Corlanor | 17 | $11,373 | $669 |
| Losartan | 728 | $10,376 | $14 |
| Amiodarone | 134 | $9,883 | $74 |
| Rosuvastatin | 220 | $9,178 | $42 |
| Ezetimibe | 133 | $8,825 | $66 |
| Pradaxa | 14 | $8,128 | $581 |
| Potassium Chloride | 205 | $6,957 | $34 |
| Amlodipine Besylate | 856 | $6,950 | $8 |
| Carvedilol | 507 | $6,740 | $13 |
| Hydralazine | 343 | $6,052 | $18 |
| Fenofibrate | 112 | $5,648 | $50 |
| Metoprolol | 519 | $4,816 | $9 |
| Midodrine | 32 | $4,549 | $142 |
| Lisinopril | 497 | $4,262 | $9 |
| Isosorbide Mononitrate Er | 202 | $4,254 | $21 |
| Furosemide | 518 | $4,017 | $8 |
| Nitroglycerin | 81 | $3,848 | $48 |
| Fenofibrate | 57 | $3,068 | $54 |
| Nebivolol | 30 | $2,500 | $83 |
| Spironolactone | 204 | $2,372 | $12 |
| Diltiazem 24hr Er (Cd) | 69 | $2,152 | $31 |
| Nifedipine Er | 64 | $1,891 | $30 |
| Valsartan | 42 | $1,859 | $44 |
| Pantoprazole | 125 | $1,852 | $15 |
| Losartan-Hydrochlorothiazide | 99 | $1,778 | $18 |
| Diltiazem 24hr Er | 29 | $1,588 | $55 |
| Warfarin | 99 | $1,419 | $14 |
| Simvastatin | 152 | $1,264 | $8 |
| Hydrochlorothiazide | 239 | $1,197 | $5 |
| Benazepril | 88 | $1,158 | $13 |
| Levothyroxine | 49 | $1,063 | $22 |
| Albuterol Sulfate Hfa | 11 | $863 | $78 |
| Dilt-Xr | 23 | $775 | $34 |
| Propranolol | 15 | $739 | $49 |
| Pravastatin | 36 | $708 | $20 |
| Valsartan-Hydrochlorothiazide | 19 | $669 | $35 |
| Diltiazem | 14 | $661 | $47 |
| Atenolol | 58 | $643 | $11 |
| Verapamil Er | 15 | $627 | $42 |
| Cilostazol | 13 | $513 | $39 |
| Omeprazole | 26 | $486 | $19 |
| Klor-Con 10 | 19 | $442 | $23 |
| Diltiazem 24hr Er (Xr) | 13 | $412 | $32 |
| Amlodipine Besylate-Benazepril | 15 | $381 | $25 |
| Allopurinol | 28 | $368 | $13 |
| Metformin | 32 | $325 | $10 |
| Escitalopram | 18 | $303 | $17 |
| Lisinopril-Hydrochlorothiazide | 14 | $271 | $19 |
| Cephalexin | 11 | $224 | $20 |
| Clonidine | 17 | $177 | $10 |
| Triamterene-Hydrochlorothiazid | 14 | $166 | $12 |
| Famotidine | 19 | $133 | $7 |
| Gabapentin | 21 | $124 | $6 |
| Tamsulosin | 13 | $96 | $7 |
2021: 72 drugs
| Eliquis | 591 | $504,773 | $854 |
| Xarelto | 211 | $220,916 | $1,047 |
| Entresto | 169 | $201,353 | $1,191 |
| Brilinta | 141 | $109,877 | $779 |
| Repatha Sureclick | 156 | $87,362 | $560 |
| Jardiance | 45 | $61,089 | $1,358 |
| Vascepa | 100 | $60,286 | $603 |
| Metoprolol | 1,397 | $30,653 | $22 |
| Atorvastatin | 1,477 | $24,553 | $17 |
| Ranolazine Er | 121 | $21,947 | $181 |
| Corlanor | 18 | $12,668 | $704 |
| Rosuvastatin | 208 | $11,736 | $56 |
| Clopidogrel | 774 | $11,317 | $15 |
| Losartan | 737 | $10,882 | $15 |
| Dexilant | 18 | $9,593 | $533 |
| Ezetimibe | 144 | $9,546 | $66 |
| Fenofibrate | 139 | $8,859 | $64 |
| Praluent | 13 | $8,548 | $658 |
| Pradaxa | 14 | $8,008 | $572 |
| Amiodarone | 147 | $8,006 | $54 |
| Amlodipine Besylate | 946 | $7,990 | $8 |
| Bystolic | 16 | $7,887 | $493 |
| Potassium Chloride | 228 | $7,632 | $33 |
| Carvedilol | 572 | $6,750 | $12 |
| Lisinopril | 609 | $4,747 | $8 |
| Isosorbide Mononitrate Er | 231 | $4,738 | $21 |
| Nitroglycerin | 118 | $4,689 | $40 |
| Hydralazine | 252 | $4,397 | $17 |
| Metoprolol | 548 | $4,329 | $8 |
| Icosapent Ethyl | 12 | $4,103 | $342 |
| Furosemide | 586 | $3,935 | $7 |
| Diltiazem 24hr Er (Cd) | 89 | $3,482 | $39 |
| Diltiazem 12hr Er | 14 | $3,266 | $233 |
| Fenofibrate | 57 | $2,883 | $51 |
| Losartan-Hydrochlorothiazide | 74 | $2,810 | $38 |
| Pantoprazole | 135 | $2,563 | $19 |
| Warfarin | 182 | $2,555 | $14 |
| Simvastatin | 251 | $2,198 | $9 |
| Spironolactone | 189 | $2,183 | $12 |
| Diltiazem 24hr Er | 37 | $2,100 | $57 |
| Midodrine | 21 | $2,012 | $96 |
| Olmesartan Medoxomil | 22 | $1,899 | $86 |
| Pacerone | 14 | $1,745 | $125 |
| Benazepril | 127 | $1,626 | $13 |
| Pravastatin | 71 | $1,504 | $21 |
| Valsartan-Hydrochlorothiazide | 27 | $1,448 | $54 |
| Cilostazol | 31 | $1,441 | $46 |
| Nifedipine Er | 44 | $1,383 | $31 |
| Valsartan | 24 | $1,369 | $57 |
| Hydrochlorothiazide | 250 | $1,339 | $5 |
| Levothyroxine | 51 | $1,295 | $25 |
| Verapamil Er | 27 | $1,019 | $38 |
| Cartia Xt | 17 | $1,003 | $59 |
| Atenolol | 74 | $963 | $13 |
| Omeprazole | 38 | $881 | $23 |
| Bumetanide | 17 | $880 | $52 |
| Digoxin | 18 | $789 | $44 |
| Amlodipine Besylate-Benazepril | 19 | $786 | $41 |
| Dilt-Xr | 27 | $761 | $28 |
| Allopurinol | 35 | $634 | $18 |
| Pentoxifylline | 11 | $592 | $54 |
| Diltiazem | 14 | $570 | $41 |
| Propranolol | 13 | $513 | $39 |
| Fenofibric Acid | 14 | $471 | $34 |
| Klor-Con 10 | 19 | $447 | $24 |
| Klor-Con 8 | 13 | $298 | $23 |
| Metformin | 24 | $227 | $9 |
| Clonidine | 20 | $193 | $10 |
| Famotidine | 16 | $187 | $12 |
| Triamterene-Hydrochlorothiazid | 12 | $173 | $14 |
| Lovastatin | 11 | $132 | $12 |
| Cephalexin | 12 | $73 | $6 |
2020: 72 drugs
| Eliquis | 516 | $388,570 | $753 |
| Xarelto | 182 | $171,641 | $943 |
| Brilinta | 173 | $109,550 | $633 |
| Entresto | 114 | $103,349 | $907 |
| Vascepa | 72 | $37,885 | $526 |
| Repatha Sureclick | 78 | $37,482 | $481 |
| Jardiance | 26 | $28,815 | $1,108 |
| Metoprolol | 1,164 | $27,889 | $24 |
| Inderal La | 53 | $22,785 | $430 |
| Atorvastatin | 1,186 | $20,989 | $18 |
| Ranolazine Er | 90 | $16,319 | $181 |
| Rosuvastatin | 151 | $12,233 | $81 |
| Januvia | 13 | $11,840 | $911 |
| Praluent | 12 | $10,097 | $841 |
| Amiodarone | 154 | $9,821 | $64 |
| Clopidogrel | 660 | $9,225 | $14 |
| Losartan | 653 | $9,056 | $14 |
| Corlanor | 14 | $8,217 | $587 |
| Dexilant | 14 | $8,182 | $584 |
| Repatha | 14 | $6,592 | $471 |
| Potassium Chloride | 201 | $6,168 | $31 |
| Ezetimibe | 87 | $6,128 | $70 |
| Fenofibrate | 104 | $5,897 | $57 |
| Carvedilol | 494 | $5,442 | $11 |
| Amlodipine Besylate | 686 | $4,811 | $7 |
| Isosorbide Mononitrate Er | 204 | $4,748 | $23 |
| Losartan-Hydrochlorothiazide | 68 | $4,607 | $68 |
| Lisinopril | 486 | $4,051 | $8 |
| Metoprolol | 472 | $3,678 | $8 |
| Furosemide | 493 | $3,449 | $7 |
| Diltiazem 24hr Er (Cd) | 67 | $3,344 | $50 |
| Fenofibrate | 44 | $3,338 | $76 |
| Nitroglycerin | 76 | $3,184 | $42 |
| Nifedipine Er | 66 | $2,388 | $36 |
| Hydralazine | 134 | $2,193 | $16 |
| Warfarin | 197 | $2,188 | $11 |
| Pantoprazole | 111 | $2,143 | $19 |
| Pravastatin | 80 | $1,858 | $23 |
| Spironolactone | 133 | $1,568 | $12 |
| Simvastatin | 214 | $1,531 | $7 |
| Cilostazol | 27 | $1,449 | $54 |
| Benazepril | 113 | $1,379 | $12 |
| Levothyroxine | 55 | $1,278 | $23 |
| Digoxin | 21 | $1,224 | $58 |
| Hydrochlorothiazide | 200 | $1,195 | $6 |
| Valsartan | 24 | $1,155 | $48 |
| Fenofibric Acid | 16 | $1,109 | $69 |
| Amlodipine Besylate-Benazepril | 25 | $1,108 | $44 |
| Dilt-Xr | 23 | $993 | $43 |
| Diltiazem 24hr Er | 25 | $969 | $39 |
| Valsartan-Hydrochlorothiazide | 15 | $925 | $62 |
| Verapamil Er | 24 | $888 | $37 |
| Diltiazem | 25 | $863 | $35 |
| Atenolol | 59 | $780 | $13 |
| Omeprazole | 51 | $777 | $15 |
| Ventolin Hfa | 13 | $749 | $58 |
| Allopurinol | 33 | $713 | $22 |
| Isosorbide Dinitrate | 18 | $661 | $37 |
| Cartia Xt | 16 | $654 | $41 |
| Bumetanide | 14 | $637 | $45 |
| Gemfibrozil | 11 | $515 | $47 |
| Propranolol | 13 | $514 | $40 |
| Captopril | 14 | $414 | $30 |
| Minoxidil | 13 | $413 | $32 |
| Propafenone | 12 | $412 | $34 |
| Tamsulosin | 13 | $271 | $21 |
| Escitalopram | 12 | $248 | $21 |
| Clonidine | 24 | $213 | $9 |
| Metformin | 15 | $163 | $11 |
| Donepezil | 15 | $118 | $8 |
| Lovastatin | 13 | $104 | $8 |
| Gabapentin | 12 | $92 | $8 |
2019: 42 drugs
| Eliquis | 151 | $95,331 | $631 |
| Brilinta | 69 | $39,150 | $567 |
| Xarelto | 34 | $36,356 | $1,069 |
| Entresto | 37 | $32,364 | $875 |
| Jardiance | 12 | $13,192 | $1,099 |
| Metoprolol | 403 | $12,449 | $31 |
| Ranolazine Er | 16 | $9,507 | $594 |
| Vascepa | 20 | $8,028 | $401 |
| Atorvastatin | 391 | $7,376 | $19 |
| Rosuvastatin | 58 | $3,600 | $62 |
| Potassium Chloride | 86 | $3,254 | $38 |
| Fenofibrate | 39 | $3,083 | $79 |
| Losartan | 247 | $2,903 | $12 |
| Amiodarone | 62 | $2,692 | $43 |
| Ezetimibe | 30 | $2,401 | $80 |
| Amlodipine Besylate | 282 | $2,353 | $8 |
| Clopidogrel | 145 | $2,057 | $14 |
| Carvedilol | 158 | $1,904 | $12 |
| Lisinopril | 200 | $1,745 | $9 |
| Furosemide | 212 | $1,631 | $8 |
| Isosorbide Mononitrate Er | 58 | $1,550 | $27 |
| Valsartan | 11 | $1,151 | $105 |
| Metoprolol | 148 | $1,109 | $7 |
| Fenofibrate | 15 | $1,041 | $69 |
| Nitroglycerin | 18 | $966 | $54 |
| Pravastatin | 46 | $853 | $19 |
| Diltiazem 24hr Er (Cd) | 31 | $839 | $27 |
| Hydralazine | 48 | $791 | $16 |
| Dilt-Xr | 12 | $676 | $56 |
| Fenofibric Acid | 11 | $629 | $57 |
| Warfarin | 47 | $595 | $13 |
| Fludrocortisone Acetate | 11 | $490 | $45 |
| Simvastatin | 53 | $476 | $9 |
| Hydrochlorothiazide | 66 | $465 | $7 |
| Pantoprazole | 30 | $459 | $15 |
| Benazepril | 29 | $449 | $15 |
| Isosorbide Dinitrate | 23 | $446 | $19 |
| Spironolactone | 37 | $423 | $11 |
| Losartan-Hydrochlorothiazide | 20 | $308 | $15 |
| Atenolol | 22 | $256 | $12 |
| Gabapentin | 12 | $139 | $12 |
| Donepezil | 18 | $82 | $5 |
2018: 32 drugs
| Eliquis | 70 | $49,835 | $712 |
| Brilinta | 42 | $30,963 | $737 |
| Xarelto | 38 | $22,358 | $588 |
| Entresto | 17 | $14,635 | $861 |
| Ranexa | 21 | $12,930 | $616 |
| Metoprolol | 182 | $7,016 | $39 |
| Atorvastatin | 245 | $4,805 | $20 |
| Rosuvastatin | 34 | $2,889 | $85 |
| Clopidogrel | 102 | $1,446 | $14 |
| Isosorbide Mononitrate Er | 47 | $1,318 | $28 |
| Fenofibrate | 18 | $1,318 | $73 |
| Amiodarone | 56 | $1,271 | $23 |
| Lisinopril | 155 | $1,125 | $7 |
| Nitroglycerin | 15 | $1,121 | $75 |
| Potassium Chloride | 21 | $1,003 | $48 |
| Losartan | 97 | $982 | $10 |
| Amlodipine Besylate | 105 | $907 | $9 |
| Diltiazem 24hr Er (Cd) | 36 | $884 | $25 |
| Carvedilol | 84 | $870 | $10 |
| Metoprolol | 92 | $723 | $8 |
| Hydralazine | 26 | $553 | $21 |
| Pravastatin | 18 | $493 | $27 |
| Spironolactone | 40 | $442 | $11 |
| Furosemide | 72 | $439 | $6 |
| Atenolol | 24 | $298 | $12 |
| Pantoprazole | 24 | $282 | $12 |
| Warfarin | 17 | $267 | $16 |
| Benazepril | 20 | $237 | $12 |
| Losartan-Hydrochlorothiazide | 13 | $200 | $15 |
| Gabapentin | 12 | $159 | $13 |
| Simvastatin | 14 | $141 | $10 |
| Hydrochlorothiazide | 13 | $108 | $8 |
2017: 30 drugs
| Xarelto | 47 | $22,050 | $469 |
| Brilinta | 39 | $17,645 | $452 |
| Effient | 16 | $11,951 | $747 |
| Eliquis | 21 | $10,200 | $486 |
| Metoprolol | 174 | $6,420 | $37 |
| Atorvastatin | 203 | $4,084 | $20 |
| Vascepa | 14 | $3,597 | $257 |
| Rosuvastatin | 21 | $2,083 | $99 |
| Omega-3 Acid Ethyl Esters | 11 | $1,816 | $165 |
| Clopidogrel | 129 | $1,433 | $11 |
| Amiodarone | 32 | $1,430 | $45 |
| Potassium Chloride | 35 | $1,296 | $37 |
| Fenofibrate | 18 | $1,154 | $64 |
| Lisinopril | 123 | $1,011 | $8 |
| Metoprolol | 102 | $939 | $9 |
| Isosorbide Mononitrate Er | 39 | $877 | $22 |
| Diltiazem 24hr Er | 34 | $851 | $25 |
| Carvedilol | 109 | $823 | $8 |
| Hydralazine | 32 | $781 | $24 |
| Amlodipine Besylate | 78 | $662 | $8 |
| Furosemide | 96 | $561 | $6 |
| Spironolactone | 39 | $418 | $11 |
| Pravastatin | 23 | $372 | $16 |
| Losartan | 46 | $354 | $8 |
| Pantoprazole | 19 | $286 | $15 |
| Valsartan | 12 | $284 | $24 |
| Losartan-Hydrochlorothiazide | 12 | $233 | $19 |
| Simvastatin | 18 | $119 | $7 |
| Gabapentin | 15 | $115 | $8 |
| Hydrochlorothiazide | 11 | $42 | $4 |
2016: 28 drugs
| Effient | 34 | $17,213 | $506 |
| Xarelto | 41 | $12,023 | $293 |
| Brilinta | 24 | $8,976 | $374 |
| Crestor | 11 | $5,826 | $530 |
| Zetia | 14 | $5,515 | $394 |
| Ranexa | 11 | $5,402 | $491 |
| Metoprolol | 125 | $4,361 | $35 |
| Vascepa | 18 | $4,359 | $242 |
| Atorvastatin | 205 | $3,872 | $19 |
| Bystolic | 11 | $3,089 | $281 |
| Clopidogrel | 93 | $1,307 | $14 |
| Isosorbide Mononitrate Er | 39 | $1,254 | $32 |
| Metoprolol | 129 | $1,097 | $9 |
| Potassium Chloride | 48 | $1,053 | $22 |
| Lisinopril | 130 | $899 | $7 |
| Amiodarone | 31 | $825 | $27 |
| Carvedilol | 93 | $633 | $7 |
| Amlodipine Besylate | 81 | $631 | $8 |
| Diltiazem 24hr Er | 23 | $610 | $27 |
| Pravastatin | 26 | $520 | $20 |
| Furosemide | 90 | $501 | $6 |
| Omeprazole | 25 | $393 | $16 |
| Spironolactone | 41 | $358 | $9 |
| Losartan | 42 | $357 | $9 |
| Pantoprazole | 31 | $311 | $10 |
| Allopurinol | 17 | $252 | $15 |
| Meclizine | 14 | $194 | $14 |
| Hydrochlorothiazide | 26 | $136 | $5 |
2015: 23 drugs
| Effient | 24 | $10,072 | $420 |
| Xarelto | 20 | $7,867 | $393 |
| Zetia | 19 | $7,505 | $395 |
| Crestor | 17 | $7,296 | $429 |
| Brilinta | 11 | $4,659 | $424 |
| Metoprolol | 109 | $4,465 | $41 |
| Atorvastatin | 166 | $4,117 | $25 |
| Potassium Chloride | 65 | $1,615 | $25 |
| Metoprolol | 126 | $1,438 | $11 |
| Lisinopril | 121 | $1,204 | $10 |
| Isosorbide Mononitrate Er | 41 | $1,102 | $27 |
| Clopidogrel | 70 | $1,010 | $14 |
| Pravastatin | 26 | $758 | $29 |
| Carvedilol | 59 | $754 | $13 |
| Amlodipine Besylate | 78 | $650 | $8 |
| Nitrostat | 14 | $444 | $32 |
| Furosemide | 85 | $406 | $5 |
| Pantoprazole | 25 | $347 | $14 |
| Losartan | 28 | $333 | $12 |
| Hydrochlorothiazide | 24 | $259 | $11 |
| Allopurinol | 16 | $238 | $15 |
| Benazepril | 16 | $115 | $7 |
| Simvastatin | 11 | $94 | $9 |
2014: 22 drugs
| Metoprolol | 94 | $5,345 | $57 |
| Atorvastatin | 141 | $3,671 | $26 |
| Effient | 11 | $2,785 | $253 |
| Fenofibrate | 15 | $1,482 | $99 |
| Isosorbide Mononitrate Er | 43 | $1,459 | $34 |
| Lisinopril | 92 | $942 | $10 |
| Metoprolol | 88 | $938 | $11 |
| Clopidogrel | 35 | $933 | $27 |
| Amlodipine Besylate | 65 | $770 | $12 |
| Carvedilol | 48 | $660 | $14 |
| Pravastatin | 15 | $618 | $41 |
| Losartan | 30 | $472 | $16 |
| Pantoprazole | 30 | $449 | $15 |
| Potassium Chloride | 16 | $352 | $22 |
| Klor-Con 10 | 12 | $336 | $28 |
| Diltiazem 24hr Er | 12 | $324 | $27 |
| Furosemide | 67 | $299 | $4 |
| Tramadol | 12 | $281 | $23 |
| Hydralazine | 11 | $275 | $25 |
| Hydrochlorothiazide | 17 | $211 | $12 |
| Simvastatin | 20 | $203 | $10 |
| Warfarin | 11 | $153 | $14 |
2013: 15 drugs
| Clopidogrel | 45 | $1,440 | $32 |
| Metoprolol | 23 | $1,409 | $61 |
| Atorvastatin | 39 | $854 | $22 |
| Isosorbide Mononitrate Er | 36 | $612 | $17 |
| Carvedilol | 21 | $291 | $14 |
| Lisinopril | 45 | $272 | $6 |
| Amlodipine Besylate | 25 | $269 | $11 |
| Potassium Chloride | 11 | $251 | $23 |
| Metoprolol | 24 | $248 | $10 |
| Furosemide | 39 | $173 | $4 |
| Warfarin | 14 | $152 | $11 |
| Bumetanide | 16 | $140 | $9 |
| Spironolactone | 11 | $138 | $13 |
| Ramipril | 11 | $118 | $11 |
| Hydrochlorothiazide | 11 | $97 | $9 |
Money from drug and device companies
$13,563 in 2025
| 2025 | 20 | 98 | $8,100 | $13,563 |
| 2024 | 20 | 124 | $11,225 | $16,903 |
| 2023 | 29 | 146 | $27,450 | $31,464 |
| 2022 | 24 | 247 | $28,500 | $37,258 |
| 2021 | 24 | 206 | $26,850 | $31,555 |
| 2020 | 22 | 126 | $14,000 | $18,823 |
| 2019 | 31 | 172 | $13,250 | $20,921 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Medtronic | Micra | $10,240 | 26 payments
|
| Abbott Laboratories | Aveir | $1,350 | 10 payments
|
| Amgen | Repatha | $348 | 13 payments
|
| Novartis Pharmaceuticals | Leqvio | $261 | 10 payments
|
| Edwards Lifesciences | Pascal | $239 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $211 | 7 payments
|
See all 98 published payments
| Abiomed | Meals · 2025-12-17 | None | $24 |
| Medtronic | Paid to speak or teach · 2025-12-16 | Micra | $2,700 |
| Amgen | Meals · 2025-12-16 | Repatha | $22 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-12-10 | Jardiance | $22 |
| Novartis Pharmaceuticals | Meals · 2025-12-03 | Leqvio | $14 |
| Amgen | Meals · 2025-11-25 | Repatha | $15 |
| Medtronic | Meals · 2025-11-21 | Micra | $39 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-18 | Adempas | $1 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-18 | Adempas | $10 |
| Amgen | Meals · 2025-11-18 | Repatha | $126 |
| Reflow Medical | Meals · 2025-11-18 | None | $17 |
| Shockwave Medical | Meals · 2025-11-13 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $36 |
| Boston Scientific | Meals · 2025-11-13 | Watchman Flx | $43 |
| Medtronic | Meals · 2025-10-30 | Corevalve Evolut R | $116 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-10-29 | Camzyos | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-29 | Kerendia | $132 |
| Pfizer | Meals · 2025-10-27 | Vyndaqel | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-23 | Kerendia | $24 |
| Novartis Pharmaceuticals | Meals · 2025-10-21 | Leqvio | $101 |
| Amgen | Meals · 2025-10-21 | Repatha | $50 |
| Biotronik | Meals · 2025-10-16 | Amvia Edge | $76 |
| Amgen | Meals · 2025-10-15 | Repatha | $13 |
| Edwards Lifesciences | Meals · 2025-09-30 | Pascal | $95 |
| Medtronic | Meals · 2025-09-27 | Symplicity G3 | $106 |
| Boston Scientific | Meals · 2025-09-25 | Watchman Flx | $67 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-09-25 | Kerendia | $17 |
| Amgen | Meals · 2025-09-25 | Repatha | $10 |
| Scpharmaceuticals | Meals · 2025-09-17 | Furoscix | $25 |
| Boston Scientific | Meals · 2025-09-11 | Varithena Administration Pack | $45 |
| Amgen | Meals · 2025-09-11 | Repatha | $20 |
| Novartis Pharmaceuticals | Meals · 2025-09-09 | Leqvio | $14 |
| Novartis Pharmaceuticals | Meals · 2025-09-09 | Leqvio | $14 |
| Abbott Laboratories | Meals · 2025-09-04 | Aveir | $156 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $17 |
| Novartis Pharmaceuticals | Meals · 2025-08-28 | Leqvio | $17 |
| Edwards Lifesciences | Meals · 2025-08-21 | Pascal | $133 |
| Pfizer | Meals · 2025-08-21 | Vyndaqel | $26 |
| Medtronic | Travel · 2025-08-18 | Micra | $176 |
| Medtronic | Meals · 2025-08-13 | Micra | $48 |
| Medtronic | Travel · 2025-08-13 | Micra | $31 |
| Medtronic | Meals · 2025-08-12 | Micra | $54 |
| Medtronic | Meals · 2025-08-12 | Micra | $4 |
| Medtronic | Travel · 2025-08-12 | Micra | $229 |
| Medtronic | Travel · 2025-08-12 | Micra | $41 |
| Medtronic | Travel · 2025-08-11 | Micra | $229 |
| Medtronic | Travel · 2025-08-11 | Micra | $41 |
| Medtronic | Travel · 2025-08-04 | Micra | $842 |
| Organogenesis | Meals · 2025-07-24 | Via Matrix | $123 |
| Actelion Pharmaceuticals US | Meals · 2025-07-17 | Opsumit | $25 |
| Amgen | Meals · 2025-07-16 | Repatha | $23 |
| Pfizer | Meals · 2025-07-16 | Eliquis | $17 |
| Bard Peripheral Vascular | Meals · 2025-07-15 | Rotarexs 6 F X 135 Cm | $16 |
| Becton Dickinson and | Meals · 2025-07-08 | Rotarexs 6 F X 135 Cm | $51 |
| Abbott Laboratories | Meals · 2025-07-07 | Mitraclip | $8 |
| Pfizer | Meals · 2025-07-02 | Vyndaqel | $22 |
| Novartis Pharmaceuticals | Meals · 2025-07-01 | Leqvio | $20 |
| Abiomed | Meals · 2025-06-10 | None | $25 |
| Medtronic | Meals · 2025-06-09 | Micra | $21 |
| Medtronic | Paid to speak or teach · 2025-05-23 | Micra | $2,700 |
| Edwards Lifesciences | Meals · 2025-05-22 | Pascal | $11 |
| Amgen | Meals · 2025-05-22 | Repatha | $16 |
| Bard Peripheral Vascular | Meals · 2025-05-20 | Rotarexs 6 F X 135 Cm | $21 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $48 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $123 |
| Abbott Laboratories | Meals · 2025-05-20 | Aveir | $60 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $123 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $81 |
| Abbott Laboratories | Travel · 2025-05-20 | Aveir | $234 |
| Medtronic | Meals · 2025-05-18 | Micra | $6 |
| Shockwave Medical | Meals · 2025-05-15 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $54 |
| Medtronic | Meals · 2025-05-09 | Micra | $10 |
| Amgen | Meals · 2025-05-09 | Repatha | $4 |
| Novartis Pharmaceuticals | Meals · 2025-05-07 | Leqvio | $22 |
| Pfizer | Meals · 2025-05-06 | Vyndaqel | $20 |
| Amgen | Meals · 2025-04-23 | Repatha | $15 |
| Medtronic | Meals · 2025-04-07 | Micra | $38 |
| Medtronic | Meals · 2025-04-07 | Micra | $15 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-04-02 | Jardiance | $14 |
| Pfizer | Meals · 2025-03-26 | Eliquis | $15 |
| Abbott Laboratories | Travel · 2025-03-18 | Aveir | $507 |
| Abbott Laboratories | Travel · 2025-03-18 | Aveir | $9 |
| Novartis Pharmaceuticals | Meals · 2025-03-05 | Leqvio | $25 |
| Medtronic | Paid to speak or teach · 2025-03-05 | None | $2,700 |
| Medtronic | Meals · 2025-03-04 | Micra | $18 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-03-04 | Jardiance | $16 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-02-25 | Adempas | $15 |
| Medtronic | Meals · 2025-02-21 | Micra | $37 |
| Medtronic | Meals · 2025-02-21 | Micra | $13 |
| Pfizer | Meals · 2025-02-18 | Vyndaqel | $20 |
| Merck Sharp & Dohme | Meals · 2025-02-18 | Verquvo | $22 |
| Amgen | Meals · 2025-02-12 | Repatha | $19 |
| Medtronic | Meals · 2025-02-07 | Micra | $24 |
| Novartis Pharmaceuticals | Meals · 2025-02-04 | Leqvio | $15 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-01-29 | Kerendia | $13 |
| Boehringer Ingelheim Pharmaceuticals | Meals · 2025-01-22 | Jardiance | $14 |
| Merck Sharp & Dohme | Meals · 2025-01-21 | Verquvo | $19 |
| Medtronic | Meals · 2025-01-16 | Corevalve Evolut R | $1 |
| Amgen | Meals · 2025-01-09 | Repatha | $15 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $16,903
| Medtronic | Micra | $15,022 | 59 payments
|
| Endologix | Endocross Device | $332 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $203 | 8 payments
|
| Amgen | Repatha | $194 | 11 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $134 | 7 payments
|
| Janssen Pharmaceuticals | Xarelto | $131 | 6 payments
|
| Novo Nordisk | Wegovy | $121 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Adempas | $105 | 6 payments
|
| Abiomed | Impella | $100 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $96 | 5 payments
|
| Novartis Pharmaceuticals | Leqvio | $95 | 5 payments
|
| United Therapeutics | None | $75 | 1 payment
|
| Kiniksa Pharmaceuticals International plc | Arcalyst | $53 | 2 payments
|
| Abbott Laboratories | Cardiomems | $50 | 2 payments
|
| Scpharmaceuticals | Furoscix | $49 | 2 payments
|
| Pfizer | Eliquis | $45 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $29 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $25 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $22 | 1 payment
|
| Heartflow | Ffrct | $22 | 1 payment
|
2023: $31,464
| Medtronic | Micra | $27,661 | 42 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $793 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $279 | 3 payments
|
| Abbott Laboratories | Navitor | $277 | 7 payments
|
| Merck Sharp & Dohme | Verquvo | $261 | 8 payments
|
| Impulse Dynamics (USA) | Optimizer | $259 | 5 payments
|
| Novartis Pharmaceuticals | Leqvio | $231 | 8 payments
|
| Abiomed | Impella | $230 | 2 payments
|
| Amgen | Repatha | $205 | 7 payments
|
| Boston Scientific | Wolverine Coronary Cutting Balloon | $198 | 13 payments
|
| Pfizer | Vyndaqel | $186 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $143 | 9 payments
|
| Scpharmaceuticals | Furoscix | $79 | 2 payments
|
| CathWorks | Ffrangio | $74 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $73 | 3 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $70 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $54 | 3 payments
|
| Terumo Medical | None | $54 | 1 payment
|
| Esperion Therapeutics | Nexletol | $53 | 3 payments
|
| Bayer Healthcare Pharmaceuticals | Adempas | $50 | 3 payments
|
| Novo Nordisk | Wegovy | $47 | 2 payments
|
| Lexicon Pharmaceuticals | Inpefa | $35 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $26 | 1 payment
|
| Amarin Pharma | Vascepa | $24 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $24 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $24 | 1 payment
|
| Kiniksa Pharmaceuticals | Arcalyst | $21 | 1 payment
|
| Cardiovascular Systems | Diamondback Peripheral | $17 | 1 payment
|
| HeartFlow | Ffrct | $16 | 1 payment
|
2022: $37,258
| Medtronic | Micra | $30,628 | 74 payments
|
| Abbott Laboratories | Aveir | $1,911 | 19 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $1,652 | 7 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $706 | 18 payments
|
| Boston Scientific | Synergy | $317 | 29 payments
|
| Impulse Dynamics (USA) | Optimizer | $273 | 5 payments
|
| Novo Nordisk | Ozempic | $240 | 15 payments
|
| Janssen Pharmaceuticals | Xarelto | $215 | 17 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $211 | 7 payments
|
| Merck Sharp & Dohme | Verquvo | $209 | 7 payments
|
| Novartis Pharmaceuticals | Leqvio | $150 | 11 payments
|
| Amgen | Repatha | $137 | 10 payments
|
| Baxter Healthcare | None | $128 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $112 | 7 payments
|
| Pfizer | Eliquis | $83 | 4 payments
|
| Biotronik | Biomonitor | $58 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $51 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $44 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $38 | 2 payments
|
| Chiesi USA | Kengreal | $35 | 2 payments
|
| CathWorks | Ffrangio | $18 | 1 payment
|
| Esperion Therapeutics | Nexletol | $16 | 1 payment
|
| Bard Peripheral Vascular | Lifestream | $14 | 1 payment
|
| AngioDynamics | Alphavac | $13 | 1 payment
|
2021: $31,555
| Medtronic | Micra | $27,542 | 74 payments
|
| Abbott Laboratories | Accent Pacemaker | $1,296 | 14 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $781 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $386 | 32 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $253 | 11 payments
|
| Esperion Therapeutics | Nexletol | $215 | 14 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $132 | 11 payments
|
| Vifor Pharma | Veltassa | $131 | 4 payments
|
| Bard Peripheral Vascular | Lifestream | $130 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $120 | 9 payments
|
| Pfizer | Eliquis | $109 | 5 payments
|
| Abiomed | Legacy | $83 | 1 payment
|
| Amgen | Repatha | $76 | 6 payments
|
| Novo Nordisk | Ozempic | $54 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $45 | 3 payments
|
| Kiniksa Pharmaceuticals | None | $34 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $29 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $27 | 2 payments
|
| Shockwave Medical | Vascular Lithotripsy | $26 | 2 payments
|
| CathWorks | Ffrangio | $23 | 1 payment
|
| Amarin Pharma | Vascepa | $21 | 1 payment
|
| Terumo Medical | Glidesheath Slender | $18 | 1 payment
|
| HeartFlow | Ffrct | $14 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $11 | 1 payment
|
2020: $18,823
| Medtronic Vascular | Micra | $11,946 | 30 payments
|
| Biotronik | Archive Brady | $4,379 | 9 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $789 | 4 payments
|
| Abbott Laboratories | Cardiomems Hf System | $409 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $244 | 17 payments
|
| Boston Scientific | General - Vascular Access | $177 | 8 payments
|
| Pfizer | Chantix | $175 | 10 payments
|
| Novartis Pharmaceuticals | Entresto | $90 | 5 payments
|
| Asahi Intecc USA | Asahi Ptca Guide Wire | $87 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $73 | 5 payments
|
| Esperion Therapeutics | Nexletol | $72 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $67 | 4 payments
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $60 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $49 | 3 payments
|
| Amgen | Repatha | $48 | 3 payments
|
| Amarin Pharma | Vascepa | $36 | 2 payments
|
| Abiomed | Impella | $33 | 2 payments
|
| Acist Medical Systems | Cvi Consumables | $29 | 2 payments
|
| CathWorks | Ffrangio System | $18 | 1 payment
|
| Philips Electronics North America | Igt D Peripheral | $17 | 1 payment
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $15 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $10 | 1 payment
|
2019: $20,921
| Medtronic Vascular | Resolute | $10,690 | 54 payments
|
| Biotronik | None | $3,485 | 7 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $2,397 | 7 payments
|
| Abbott Laboratories | Mitra Clip System | $1,551 | 22 payments
|
| Baylis Medical Company | Nrg Needle | $909 | 1 payment
|
| Abiomed | Impella | $458 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $317 | 16 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $200 | 9 payments
|
| Pfizer | Eliquis | $146 | 13 payments
|
| Novartis Pharmaceuticals | Entresto | $140 | 5 payments
|
| United Therapeutics | Orenitram | $81 | 1 payment
|
| Boston Scientific | Jetstream | $67 | 4 payments
|
| Amarin Pharma | Vascepa | $47 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $46 | 3 payments
|
| Philips Electronics North America | Trilogy 100 | $42 | 2 payments
|
| Aziyo Biologics | Ecm Patch,Pouch | $39 | 2 payments
|
| Sanofi-Aventis U.S. | Praluent | $35 | 2 payments
|
| Amgen | Repatha | $32 | 2 payments
|
| Acist Medical Systems | Cvi Systems | $29 | 3 payments
|
| Osprey Medical | Dyevert | $27 | 1 payment
|
| Ra Medical Systems | Dabra | $25 | 1 payment
|
| Gilead Sciences | None | $23 | 1 payment
|
| Cardiovascular Systems | Peripheral Orbital Atherectomy System | $21 | 1 payment
|
| Astellas Pharma US | Lexiscan | $21 | 1 payment
|
| CathWorks | Ffrangio System | $17 | 1 payment
|
| Terumo Medical | Glidesheath | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $13 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $13 | 1 payment
|
| Bard Peripheral Vascular | Lutonix | $12 | 1 payment
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $5 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Medtronic, Inc. · Alleviate-Hf · 2021 | Their institution | $31,898 |
| Medtronic, Inc. · Alleviate-Hf · 2025 | Their institution | $24,399 |
| Medtronic, Inc. · Alleviate-Hf · 2022 | Their institution | $19,875 |
| Medtronic Vascular, Inc. · Revamp · 2020 | Their institution | $19,874 |
| Medtronic, Inc. · Accelav Study · 2021 | Their institution | $15,337 |
| Medtronic Vascular, Inc. · Accelav Study · 2020 | Their institution | $11,500 |
| Medtronic Vascular, Inc. · Revamp · 2019 | Their institution | $10,685 |
| Medtronic, Inc. · Alleviate-Hf · 2024 | Their institution | $7,057 |
| Medtronic, Inc. · Alleviate-Hf · 2023 | Their institution | $6,004 |
| CathWorks, Inc. · All-Rise · 2025 | Their institution | $5,245 |
| Medtronic, Inc. · Accelav Study · 2022 | Their institution | $1,315 |
| Medtronic Vascular, Inc. · Alleviate-Hf · 2020 | Their institution | $96 |
Checkups this office reported
14 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Advance care plan on fileOlder patients with an advance care plan or a documented conversation about one | 1%That's few of the people this applied to. | 2,670 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 37%That's less than half. | 3,229 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 68%That's more than half. | 1,980 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Preoperative Evaluation in Low-Risk Surgery PatientsAs Medicare defines this measure | 0% | 465 |
| Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Testing in Asymptomatic, Low-Risk PatientsAs Medicare defines this measure | 0% | 465 |
| Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 85% | 413 |
| Coronary Artery Disease (CAD): Antiplatelet TherapyAs Medicare defines this measure | 78% | 1,296 |
| Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 93% | 155 |
See the other 6 measures
| Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) or Angiotensin Receptor-Neprilysin Inhibitor (ARNI) Therapy for Left Ventricular Systolic Dysfunction (LVSD)As Medicare defines this measure | 89% | 186 |
| Medications listed in the chartVisits where the current medication list was documented | 90%That's most of the people this applied to. | 8,186 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 2,482 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 32% | 2,123 |
| Statin prescribed when it protects the heartPeople at cardiovascular risk who were prescribed a statin | 83%That's most of the people this applied to. | 2,386 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 96%That's most of the people this applied to. | 3,907 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1679581268
- Licence
- CA 20A1923, CA 20A9123
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 20A1923
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X); Internal medicine (207R00000X); Cardiology (207RC0000X)
- Mailing address
- 2800 N California St, Suite 14a, Stockton, CA, 95204
- NPI first listed
- 2006-08-03
- NPI last updated
- 2014-01-22
This is when the NPI record was last certified, not a medical board exam.